ALC:NYE-Alcon AG (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 89.57

Change

+0.01 (+0.01)%

Market Cap

USD 44.97B

Volume

0.87M

Analyst Target

USD 65.36
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-20 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

-0.50 (-0.22%)

USD 66.00B
RMD ResMed Inc

-1.10 (-0.47%)

USD 34.83B
BAX Baxter International Inc

+0.38 (+1.14%)

USD 16.62B
AVTR Avantor Inc

-0.19 (-1.09%)

USD 13.05B
ATR AptarGroup Inc

-0.34 (-0.23%)

USD 10.46B
TFX Teleflex Incorporated

+0.51 (+0.29%)

USD 7.78B
BLCO Bausch + Lomb Corp

-0.14 (-0.88%)

USD 6.11B
STVN Stevanato Group SpA

+0.43 (+2.10%)

USD 5.98B
WRBY Warby Parker Inc

-1.22 (-4.82%)

USD 3.17B
INFU InfuSystems Holdings Inc

-0.50 (-6.13%)

USD 0.17B

ETFs Containing ALC

CHSRI:SW UBS ETF (CH) - MSCI Switz.. 5.01 % 0.00 %

+0.10 (+0%)

N/A
CHSRIA:SW UBS ETF (CH) MSCI Switzer.. 5.01 % 0.00 %

+0.15 (+0%)

N/A
CHSR:XETRA 5.00 % 0.00 %

N/A

N/A
CHSRII:SW UBS(Lux)Fund Solutions .. 4.98 % 0.00 %

+0.12 (+0%)

N/A
XSLI:SW Xtrackers SLI UCITS ETF 1.. 4.44 % 0.00 %

+1.15 (+0%)

USD 0.31B
SLICHA:SW UBS ETF (CH) – SLI® (C.. 4.43 % 0.00 %

+1.75 (+0%)

USD 32,912.73B
CSSLI:SW iShares SLI® ETF (CH) 4.42 % 0.00 %

+1.85 (+0%)

USD 0.67B
SMIEX:SW iShares SLI UCITS ETF (DE.. 4.40 % 0.00 %

+1.08 (+0%)

USD 5,933.96B
CBCH30:SW 3.78 % 0.00 %

N/A

N/A
XSMC:SW Xtrackers Switzerland UCI.. 3.16 % 0.00 %

+1.32 (+0%)

USD 0.50B
XSMI:SW Xtrackers Switzerland UCI.. 3.16 % 0.00 %

+1.54 (+0%)

USD 1.35B
SMICHA:SW UBS ETF (CH) – SMI® (C.. 3.16 % 0.00 %

+1.58 (+0%)

USD 17,142.72B
XSMI:XETRA 3.15 % 0.00 %

N/A

N/A
CSSMI:SW iShares SMI® ETF (CH) 3.15 % 0.00 %

+1.42 (+0%)

USD 2.12B
ESRU:LSE Amundi Index Solutions - .. 3.12 % 0.00 %

+0.36 (+0%)

N/A
ESDU:LSE Amundi Index Solutions - .. 3.09 % 0.00 %

N/A

N/A
ACU7:XETRA 2.99 % 0.00 %

N/A

N/A
ESRG:LSE Amundi Index Solutions - .. 2.97 % 0.00 %

N/A

USD 2.02B
ESDG:LSE Amundi Index Solutions - .. 2.97 % 0.00 %

+22.00 (+0%)

USD 0.19B
CHEUR:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

+0.06 (+0%)

N/A
CHEURD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
CHUSD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

+0.02 (+0%)

N/A
CHUSDD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
STWX:SW SPDR® MSCI Europe Health.. 2.71 % 0.00 %

+3.10 (+0%)

USD 0.69B
SXDPEX:SW iShares STOXX Europe 600 .. 2.56 % 0.00 %

N/A

USD 0.44B
SPICHA:SW UBS ETF (CH) – SPI® (C.. 2.52 % 0.00 %

+0.75 (+0%)

USD 131,872.43B
HEAE:LSE SPDR® MSCI Europe Health.. 2.50 % 0.00 %

+2.28 (+0%)

N/A
ASRP:XETRA 2.26 % 0.00 %

N/A

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.10 % 0.00 %

+0.07 (+0%)

N/A
EWL iShares MSCI Switzerland .. 0.00 % 0.47 %

+0.33 (+0%)

N/A
LNGR 0.00 % 0.50 %

N/A

N/A
RNDM 0.00 % 0.65 %

N/A

N/A
FLSW Franklin FTSE Switzerland.. 0.00 % 0.09 %

+0.21 (+0%)

USD 0.06B
HLTH:LSE SPDR® MSCI Europe Health.. 0.00 % 0.00 %

+3.30 (+0%)

N/A
XSDR:LSE Xtrackers MSCI Europe Hea.. 0.00 % 0.00 %

+277.00 (+0%)

USD 0.21B
UC93:LSE UBS MSCI Switzerland 20/3.. 0.00 % 0.00 %

+28.50 (+0%)

USD 8.77M
UC94:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

+30.00 (+0%)

USD 0.07B
EUSRI:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.60 (+0%)

USD 2.09B
STW:PA SPDR® MSCI Europe Health.. 0.00 % 0.00 %

+3.55 (+0%)

USD 0.71B
C030:F 0.00 % 0.00 %

N/A

N/A
DBXS:F 0.00 % 0.00 %

N/A

N/A
DXS0:F 0.00 % 0.00 %

N/A

N/A
DXSE:F 0.00 % 0.00 %

N/A

N/A
EL4X:F 0.00 % 0.00 %

N/A

N/A
EXI1:F 0.00 % 0.00 %

N/A

N/A
EXV4:F 0.00 % 0.00 %

N/A

N/A
EXV5:F 0.00 % 0.00 %

N/A

N/A
MIVB:F 0.00 % 0.00 %

N/A

N/A
SPYH:F 0.00 % 0.00 %

N/A

N/A
C030:XETRA 0.00 % 0.00 %

N/A

N/A
DBXS:XETRA 0.00 % 0.00 %

N/A

N/A
DXS0:XETRA 0.00 % 0.00 %

N/A

N/A
DXSE:XETRA 0.00 % 0.00 %

N/A

N/A
EXI1:XETRA 0.00 % 0.00 %

N/A

N/A
EXV4:XETRA 0.00 % 0.00 %

N/A

N/A
MIVB:XETRA 0.00 % 0.00 %

N/A

N/A
SPYH:XETRA 0.00 % 0.00 %

N/A

N/A
1391:TSE 0.00 % 0.00 %

N/A

N/A
CHSPI:SW iShares Core SPI® ETF (C.. 0.00 % 0.00 %

+1.30 (+0%)

USD 4.02B
SW2CHA:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

+0.26 (+0%)

USD 0.49B
SW2CHB:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

+0.33 (+0%)

USD 1.75B
SW2UKD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

+0.21 (+0%)

USD 0.04B
SWICHA:SW UBS ETF (CH) – MSCI Swi.. 0.00 % 0.00 %

+0.21 (+0%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Swi.. 0.00 % 0.00 %

+0.47 (+0%)

USD 226,274.21B
CEFA Global X S&P Catholic Val.. 0.00 % 0.00 %

-0.12 (0%)

USD 0.02B
AGNG Global X Aging Population.. 0.00 % 0.00 %

+0.06 (+0%)

USD 0.06B
ESIH:LSE iShares MSCI Europe Healt.. 0.00 % 0.00 %

+0.08 (+0%)

USD 0.81B
ESIH:F 0.00 % 0.00 %

N/A

N/A
ESIH:XETRA 0.00 % 0.00 %

N/A

N/A
CHDIV:SW UBS ETF (CH) - MSCI Switz.. 0.00 % 0.00 %

+0.02 (+0%)

USD 1,244,681.59B
S2HGBD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.07B
SWEUAH:SW UBS ETF (CH) – MSCI Swi.. 0.00 % 0.00 %

-0.07 (0%)

USD 226,274.20B
S2HGBA:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

-0.07 (0%)

USD 8.53M

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.51% 74% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.51% 74% C 71% C-
Trailing 12 Months  
Capital Gain 11.41% 79% B- 62% D
Dividend Return 0.33% 30% F 3% F
Total Return 11.73% 79% B- 55% F
Trailing 5 Years  
Capital Gain 41.19% 94% A 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.19% 94% A 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 11.66% 74% C 68% D+
Dividend Return 11.92% 74% C 63% D
Total Return 0.26% 30% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 17.31% 89% A- 61% D-
Risk Adjusted Return 68.88% 100% F 79% B-
Market Capitalization 44.97B 93% A 95% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.